These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14662025)

  • 41. Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO.
    Krause P; Singer E; Darley PI; Klebensberger J; Groettrup M; Legler DF
    J Leukoc Biol; 2007 Nov; 82(5):1106-14. PubMed ID: 17698915
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells.
    Scandella E; Men Y; Gillessen S; Förster R; Groettrup M
    Blood; 2002 Aug; 100(4):1354-61. PubMed ID: 12149218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of high expression of CCR7 and high production of IL-12 in human monocyte-derived dendritic cells by a new bacterial component: LCOS 1013.
    Gillet-Hladky S; Duperrier K; Picandet S; Mathias V; de Carvalho MC; Bernaud J; Masseau D; Bienvenu J; Rigal D
    Int Immunopharmacol; 2008 Sep; 8(9):1151-63. PubMed ID: 18602060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leukotriene C4 induces migration of human monocyte-derived dendritic cells without loss of immunostimulatory function.
    Dannull J; Schneider T; Lee WT; de Rosa N; Tyler DS; Pruitt SK
    Blood; 2012 Mar; 119(13):3113-22. PubMed ID: 22323449
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interferon-gamma dose-dependently inhibits prostaglandin E2-mediated dendritic-cell-migration towards secondary lymphoid organ chemokines.
    Alder J; Hahn-Zoric M; Andersson BA; Karlsson-Parra A
    Vaccine; 2006 Nov; 24(49-50):7087-94. PubMed ID: 16889876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In-Depth Analysis of the Impact of Different Serum-Free Media on the Production of Clinical Grade Dendritic Cells for Cancer Immunotherapy.
    Calmeiro J; Mendes L; Duarte IF; Leitão C; Tavares AR; Ferreira DA; Gomes C; Serra J; Falcão A; Cruz MT; Carrascal MA; Neves BM
    Front Immunol; 2020; 11():593363. PubMed ID: 33613517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M; Falkner DH; Morel PA
    J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation.
    Toniolo PA; Liu S; Yeh JE; Moraes-Vieira PM; Walker SR; Vafaizadeh V; Barbuto JA; Frank DA
    J Immunol; 2015 Apr; 194(7):3180-90. PubMed ID: 25725100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes.
    Canning MO; Grotenhuis K; de Wit H; Ruwhof C; Drexhage HA
    Eur J Endocrinol; 2001 Sep; 145(3):351-7. PubMed ID: 11517017
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mixture of fibroblast, epithelial and endothelial cells conditioned media induce monocyte-derived dendritic cell maturation.
    GanjiBakhsh M; Nejati V; Delirezh N; Asadi M; Gholami K
    Cell Immunol; 2011; 272(1):18-24. PubMed ID: 22035776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs.
    Rubio MT; Means TK; Chakraverty R; Shaffer J; Fudaba Y; Chittenden M; Luster AD; Sykes M
    Int Immunol; 2005 Dec; 17(12):1561-72. PubMed ID: 16303787
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IFN-beta inhibits dendritic cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9.
    Yen JH; Kong W; Ganea D
    J Immunol; 2010 Apr; 184(7):3478-86. PubMed ID: 20190134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of oxygen levels on the physiology of dendritic cells: implications for adoptive cell therapy.
    Futalan D; Huang CT; Schmidt-Wolf IG; Larsson M; Messmer D
    Mol Med; 2011; 17(9-10):910-6. PubMed ID: 21647537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic and functional characterization of mature dendritic cells from pediatric cancer patients.
    Jacobs JF; Hoogerbrugge PM; de Rakt MW; Aarntzen EH; Figdor CG; Adema GJ; de Vries IJ
    Pediatr Blood Cancer; 2007 Dec; 49(7):924-7. PubMed ID: 17486645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proteoglycans regulate the chemotaxis of dendritic cells derived from human peripheral blood monocytes.
    Yoshino H; Takahashi K; Monzen S; Kashiwakura I
    Biol Pharm Bull; 2010; 33(6):938-44. PubMed ID: 20522956
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Macrophage colony-stimulating factor drives cord blood monocyte differentiation into IL-10(high)IL-12absent dendritic cells with tolerogenic potential.
    Li G; Kim YJ; Broxmeyer HE
    J Immunol; 2005 Apr; 174(8):4706-17. PubMed ID: 15814695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes.
    Hirao M; Onai N; Hiroishi K; Watkins SC; Matsushima K; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Apr; 60(8):2209-17. PubMed ID: 10786686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Triggering of NF-κB in cytokine-matured human DCs generates superior DCs for T-cell priming in cancer immunotherapy.
    Pfeiffer IA; Hoyer S; Gerer KF; Voll RE; Knippertz I; Gückel E; Schuler G; Schaft N; Dörrie J
    Eur J Immunol; 2014 Nov; 44(11):3413-28. PubMed ID: 25100611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficient migration of dendritic cells toward lymph node chemokines and induction of T(H)1 responses require maturation stimulus and apoptotic cell interaction.
    Bertho N; Adamski H; Toujas L; Debove M; Davoust J; Quillien V
    Blood; 2005 Sep; 106(5):1734-41. PubMed ID: 15899913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.